Skip to main content
  Tuesday, 27 February 2024
  1 Replies
  1.4K Visits
For patients with non-valvular atrial fibrillation and no history of GI bleed, is apixaban 2.5mg po bid a reasonable alternative to warfarin target INR 2-3?
4 months ago

The data are very limited in this group as you know. We have been using DOACs in our dialysis patients but clearly it is without ironclad evidence and support.

I believe that future clinical trials will be very helpful in clarifying this point but until then it is definitely a judgement call.

Dr. Jordan Weinstein
  • Page :
  • 1
There are no replies made for this post yet.
Submit Your Response
Upload files or images for this discussion by clicking on the upload button below.
Supported: gif,jpg,png,zip,rar,pdf,jpeg,doc,docx,xls,xlsx
· Insert · Remove
  Upload Files (Maximum 10MB)

Sharing your current location while posting a new question allow viewers to identify the location you are located.